Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Viridian Therapeutics, Inc.\DE | exh_311.htm |
| EX-32.1 - EXHIBIT 32.1 - Viridian Therapeutics, Inc.\DE | exh_321.htm |
| EX-31.2 - EXHIBIT 31.2 - Viridian Therapeutics, Inc.\DE | exh_312.htm |
| EX-10.31 - EXHIBIT 10.31 - Viridian Therapeutics, Inc.\DE | exh_1031.htm |
| 10-K - FORM 10-K - Viridian Therapeutics, Inc.\DE | f10k_032116p.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Signal Genetics, Inc.
Carlsbad, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-205618 and 333-205620) and Form S-8 (No. 333-197316) of Signal Genetics, Inc. of our report dated March 21, 2016, relating to the consolidated financial statements which appears in this Annual Report on Form 10-K for the year ended December 31, 2015.
/s/ BDO USA, LLP
San Diego, California
March 21, 2016